The increased incidence of de novo gastroesophageal reflux disease (GERD) after sleeve
gastrectomy (SG) along with its consequences, including the potential transformation
into Barrett’s esophagus (BE) and ultimately esophageal cancer, impelled an increased
number of publications on this subject. In an attempt to better understand the true
incidence of BE after two commonly performed bariatric procedures, laparoscopic SG
and laparoscopic Roux-en-Y gastric bypass (RYGB), Wo¨lnerhanssen et al. prospectively
studied a cohort of 169 patients (86 RYGB and 83 SG) to evaluate the postoperative
development of BE after at least 5 years of follow-up. After a median of 7.0±1.5 years,
the incidence of BE in SG and RYGB group were 3.6% vs. 1.2% respectively (p=0.362),
concluding that there was no statistically significant increased risk of BE after
SG compared to RYGB. On the other hand, patients in the SG group did have higher rates
of dyspeptic symptoms, reflux esophagitis, pathological acid exposure and use of proton
pump inhibitors when compared to RYGB. Of note, 22 patients were converted from sleeve
to bypass and were excluded from the analysis and this could have skewed the reported
outcomes.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgery for Obesity and Related DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References:
- Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review.Surg Obes Relat Dis. 2011; 7: 510-515
- Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.Jama. 2018; 319: 255-265
- Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.JAMA Surg. 2022; 157: 656-666
- Prevalence of Barrett's esophagus in the general population: an endoscopic study.Gastroenterology. 2005; 129: 1825-1831
- IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures.Obes Surg. 2020; 30: 3135-3153
- ASGE guideline on screening and surveillance of Barrett's esophagus.Gastrointest Endosc. 2019; 90: 335-359.e2
- Esophageal cancer after sleeve gastrectomy: a population-based comparative cohort study.Surg Obes Relat Dis. 2021; 17: 879-887
Article info
Publication history
Accepted:
March 12,
2023
Received:
March 3,
2023
Publication stage
In Press Journal Pre-ProofFootnotes
Conflict of Interest:
The authors declare no conflict of interest.
Funding Sources:
The authors received no financial support for the research and authorship of this article.
Identification
Copyright
© 2023 Published by Elsevier Inc. on behalf of American Society for Metabolic and Bariatric Surgery.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Prospective clinical cohort study: low incidence of Barrett esophagus but high rate of reflux disease at 5-year follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypassSurgery for Obesity and Related DiseasesOpen Access
